The Prognostic Value of the Inflammation-Immunity-Nutrition Score in Advanced Non-Small Cell Lung Cancer Undergoing First-Line Immunotherapy: A 3-Year Retrospective Cohort Study

OBJECTIVE: This study preliminarily evaluated the prognostic value of the inflammation-immunity-nutrition score (IINS) in advanced NSCLC patients receiving first-line immunotherapy. METHODS: This retrospective, single-center study enrolled 212 patients. Patients were categorized into the death group, survival group, progressive disease (PD) group, and non-PD (N-PD) group. Prognosis analysis employed Cox regression, Kaplan-Meier (KM) survival curves, and ROC curves. Internal validation was performed using the Bootstrap method and a 10-fold cross-validation approach, and calibration curves were plotted. RESULTS: High IINS was associated with poorly differentiated tumors, stage IV disease, and ≥2 metastases. Patients with PD or death had significantly higher IINS. After adjusting for available confounding factors, a higher IINS remained associated with PD and death. IINS may aid in the prognostic assessments of PD and death within 3 years, with good model performance in internal validation. High-risk patients showed reduced survival. CONCLUSION: Higher IINS correlates with poor 3-year prognosis. Given the limitations of the retrospective, single-center design, the absence of a non-immunotherapy control group, and the failure to adjust for certain key confounding factors, the above conclusions should be regarded as preliminary, hypothesis-generating findings that require external validation through prospective, multicenter studies.

Authors

Institutions

Publication Details

Journal
Biomarkers
Published
2026-11-16
DOI
https://doi.org/10.1080/1354750x.2026.2765438
Primary Topic
Inflammatory Biomarkers in Disease Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The Prognostic Value of the Inflammation-Immunity-Nutrition Score in Advanced Non-Small Cell Lung Cancer Undergoing First-Line Immunotherapy: A 3-Year Retrospective Cohort Study

Zuo Jian-hui, Kai Cui, Wen-jian Liu
5 links
Biomarkers
Inflammatory Biomarkers in Disease Prognosis
article

The Prognostic Value of the Inflammation-Immunity-Nutrition Score in Advanced Non-Small Cell Lung Cancer Undergoing First-Line Immunotherapy: A 3-Year Retrospective Cohort Study

Zuo Jian-hui, Kai Cui, Wen-jian Liu
article en

Abstract

OBJECTIVE: This study preliminarily evaluated the prognostic value of the inflammation-immunity-nutrition score (IINS) in advanced NSCLC patients receiving first-line immunotherapy. METHODS: This retrospective, single-center study enrolled 212 patients. Patients were categorized into the death group, survival group, progressive disease (PD) group, and non-PD (N-PD) group. Prognosis analysis employed Cox regression, Kaplan-Meier (KM) survival curves, and ROC curves. Internal validation was performed using the Bootstrap method and a 10-fold cross-validation approach, and calibration curves were plotted. RESULTS: High IINS was associated with poorly differentiated tumors, stage IV disease, and ≥2 metastases. Patients with PD or death had significantly higher IINS. After adjusting for available confounding factors, a higher IINS remained associated with PD and death. IINS may aid in the prognostic assessments of PD and death within 3 years, with good model performance in internal validation. High-risk patients showed reduced survival. CONCLUSION: Higher IINS correlates with poor 3-year prognosis. Given the limitations of the retrospective, single-center design, the absence of a non-immunotherapy control group, and the failure to adjust for certain key confounding factors, the above conclusions should be regarded as preliminary, hypothesis-generating findings that require external validation through prospective, multicenter studies.

Biomarkers
First Affiliated Hospital of Anhui Medical University (CN)
Good health and well-being
Inflammatory Biomarkers in Disease Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon